PIPELINE THERAPEUTICS Revenue and Competitors
Estimated Revenue & Valuation
- PIPELINE THERAPEUTICS's estimated annual revenue is currently $8M per year.
- PIPELINE THERAPEUTICS's estimated revenue per employee is $201,000
Employee Data
- PIPELINE THERAPEUTICS has 40 Employees.
- PIPELINE THERAPEUTICS grew their employee count by 11% last year.
PIPELINE THERAPEUTICS's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Senior Director Chemistry | Reveal Email/Phone |
2 | Chief Scientific Officer | Reveal Email/Phone |
3 | Director Pharmacology | Reveal Email/Phone |
4 | Scientist II | Reveal Email/Phone |
5 | Research Scientist | Reveal Email/Phone |
PIPELINE THERAPEUTICS Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 673 | 0% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1725 | 2% | N/A | N/A |
#10 | $10.5M | 52 | 4% | N/A | N/A |
What Is PIPELINE THERAPEUTICS?
Pipeline Therapeutics is a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for neuroregeneration, including synaptogenesis, remyelination and axonal repair. The company's lead product candidate, PIPE-505, is a small molecule gamma secretase inhibitor (GSI) to treat mild-to-moderate sensorineural hearing loss (SNHL) associated with cochlear synaptopathy. The company also has a portfolio of programs, including PIPE-307, focused on remyelination and axonal repair, to address a range of neurological disorders, including multiple sclerosis.
keywords:N/A
N/A
Total Funding
40
Number of Employees
$8M
Revenue (est)
11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
PIPELINE THERAPEUTICS News
Essential HER2 negative Breast Cancer pipeline therapies such as BGB-290, OP-1250, AZD9833, Elacestrant, ADG106, H3B-6545, Dato-DXd,...
Pipeline Therapeutics is a clinical-stage biopharmaceutical company pioneering the development and commercialization of first-in-class...
Pipeline Therapeutics is a clinical-stage biopharmaceutical company pioneering the development and commercialization of first-in-class therapies...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $8.1M | 40 | -7% | N/A |
#2 | $4.6M | 40 | -13% | N/A |
#3 | $4.6M | 40 | 0% | N/A |
#4 | $4.6M | 40 | N/A | N/A |
#5 | $9.9M | 40 | 0% | $10.8M |